Kai Hu

732 total citations
59 papers, 456 citations indexed

About

Kai Hu is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Kai Hu has authored 59 papers receiving a total of 456 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Hematology, 20 papers in Oncology and 19 papers in Molecular Biology. Recurrent topics in Kai Hu's work include Acute Myeloid Leukemia Research (21 papers), Lymphoma Diagnosis and Treatment (18 papers) and CAR-T cell therapy research (16 papers). Kai Hu is often cited by papers focused on Acute Myeloid Leukemia Research (21 papers), Lymphoma Diagnosis and Treatment (18 papers) and CAR-T cell therapy research (16 papers). Kai Hu collaborates with scholars based in China, United States and Australia. Kai Hu's co-authors include Hongmei Jing, Jinlong Shi, Lin Fu, Xiaoyan Ke, Ping Yang, Jijun Wang, Xiuru Zhang, Xue He, Xiaoni Liu and Yifan Pang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Scientific Reports.

In The Last Decade

Kai Hu

53 papers receiving 452 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kai Hu China 13 220 130 106 106 74 59 456
Jeff Kutok United States 6 226 1.0× 108 0.8× 65 0.6× 50 0.5× 54 0.7× 10 428
Heather Geiger United States 9 231 1.1× 144 1.1× 56 0.5× 112 1.1× 38 0.5× 14 432
Junji Koya Japan 13 291 1.3× 89 0.7× 177 1.7× 93 0.9× 30 0.4× 35 523
Mary Lowery Nordberg United States 9 161 0.7× 127 1.0× 85 0.8× 46 0.4× 76 1.0× 26 390
Maria Antonella Laginestra Italy 12 147 0.7× 144 1.1× 37 0.3× 104 1.0× 151 2.0× 25 382
Andrea N. Marcogliese United States 9 158 0.7× 187 1.4× 78 0.7× 58 0.5× 66 0.9× 23 381
Michele Gottardi Italy 13 202 0.9× 136 1.0× 263 2.5× 57 0.5× 63 0.9× 37 579
Ji Xu China 15 325 1.5× 178 1.4× 129 1.2× 214 2.0× 103 1.4× 50 641
Alexis Talbot France 11 191 0.9× 180 1.4× 111 1.0× 41 0.4× 37 0.5× 46 409
Maximilian Merz Germany 14 360 1.6× 246 1.9× 324 3.1× 58 0.5× 34 0.5× 54 670

Countries citing papers authored by Kai Hu

Since Specialization
Citations

This map shows the geographic impact of Kai Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kai Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kai Hu more than expected).

Fields of papers citing papers by Kai Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kai Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kai Hu. The network helps show where Kai Hu may publish in the future.

Co-authorship network of co-authors of Kai Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Kai Hu. A scholar is included among the top collaborators of Kai Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kai Hu. Kai Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xue, Fei, Rui Liu, Fan Yang, et al.. (2025). Sequential CD19-20 CAR T-cell therapy for refractory/relapsed diffuse large B-cell lymphoma. Cytotherapy. 27(8). 910–916.
2.
Dou, Yimeng, Rui Liu, Fan Yang, et al.. (2025). Efficacy and Safety of CART Cell Therapy in Aggressive B‐Cell Lymphomas Involving the Gastrointestinal Tract. Cancer Reports. 8(1). e70083–e70083.
3.
4.
Liu, Rui, Fan Yang, Biping Deng, et al.. (2024). Utilizing BTK Inhibitors for Maintenance and Long-Term Control Following CAR-T Cell Therapy in B-Cell Non-Hodgkin Lymphoma. Blood. 144(Supplement 1). 6183–6183. 1 indexed citations
5.
Xue, Fei, Fan Yang, Rui Liu, et al.. (2024). Salvage CD20-SD-CART therapy in aggressive B-cell lymphoma after CD19 CART treatment failure. Frontiers in Oncology. 14. 1376490–1376490. 2 indexed citations
6.
Chen, Wei, Hui Shi, Zhuojun Liu, et al.. (2023). Single-Cell Transcriptomics Reveals Immune Reconstitution in Patients with R/R T-ALL/LBL Treated with Donor-Derived CD7 CAR-T Therapy. Clinical Cancer Research. 29(8). 1484–1495. 20 indexed citations
7.
8.
Zhang, Weilong, Jing Wang, Wei Li, et al.. (2023). The expression level of Neuronal Calcium Sensor 1 can predict the prognosis of cytogenetically normal AML. The Pharmacogenomics Journal. 23(4). 89–94.
9.
10.
Tian, Lei, Hui Shi, Jing Wang, et al.. (2021). Genetic Landscape of Relapsed and Refractory Diffuse Large B-Cell Lymphoma: A Systemic Review and Association Analysis With Next-Generation Sequencing. Frontiers in Genetics. 12. 677650–677650. 3 indexed citations
11.
Lai, Rui, Weilong Zhang, Xue He, et al.. (2020). Prognostic role of ACTL10 in Cytogenetic Normal Acute Myeloid Leukemia. Journal of Cancer. 11(17). 5150–5161. 6 indexed citations
12.
Zhang, Weilong, Xue He, Xiaoni Liu, et al.. (2019). High NCALD expression predicts poor prognosis of cytogenetic normal acute myeloid leukemia. Journal of Translational Medicine. 17(1). 166–166. 11 indexed citations
13.
Zhang, Weilong, Ling Cao, Xiaoni Liu, et al.. (2019). High expression of CHML predicts poor prognosis of multiple myeloma. Journal of Cancer. 10(24). 6048–6056. 1 indexed citations
14.
Pang, Yifan, Jilei Zhang, Jinlong Shi, et al.. (2019). High Expression Levels of ACTN1 and ACTN3 Indicate Unfavorable Prognosis in Acute Myeloid Leukemia. Journal of Cancer. 10(18). 4286–4292. 17 indexed citations
15.
Cheng, Zhiheng, Lei Zhou, Kai Hu, et al.. (2018). Prognostic significance of microRNA-99a in acute myeloid leukemia patients undergoing allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplantation. 53(9). 1089–1095. 9 indexed citations
16.
Cheng, Zhiheng, Yifeng Dai, Yifan Pang, et al.. (2018). Clinical and Biological Implications of Mutational Spectrum in Acute Myeloid Leukemia of FAB Subtypes M0 and M1. Cellular Physiology and Biochemistry. 47(5). 1853–1861. 3 indexed citations
17.
Cheng, Zhiheng, Kai Hu, Lei Tian, et al.. (2018). Clinical and biological implications of mutational spectrum in acute myeloid leukemia of FAB subtypes M4 and M5. Cancer Gene Therapy. 25(3-4). 77–83. 11 indexed citations
18.
Zhang, Weilong, Xiaoni Liu, Xue He, et al.. (2018). Prediction and prognostic significance of BCAR3 expression in patients with multiple myeloma. Journal of Translational Medicine. 16(1). 363–363. 12 indexed citations
19.
Zhang, Jilei, Xinpei Zhang, Gaoqi Zhang, et al.. (2018). High expression levels of SMAD3 and SMAD7 at diagnosis predict poor prognosis in acute myeloid leukemia patients undergoing chemotherapy. Cancer Gene Therapy. 26(5-6). 119–127. 12 indexed citations
20.
Hu, Kai. (2007). Immune function effect of interleukin-2 combined with minor bupleurum decoction on autologous haemopoietic stem cell transplantation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jeff Kutok Breakdown of academic impact, for papers by Heather Geiger Breakdown of academic impact, for papers by Junji Koya Breakdown of academic impact, for papers by Mary Lowery Nordberg Breakdown of academic impact, for papers by Maria Antonella Laginestra Breakdown of academic impact, for papers by Andrea N. Marcogliese Breakdown of academic impact, for papers by Michele Gottardi Breakdown of academic impact, for papers by Ji Xu Breakdown of academic impact, for papers by Alexis Talbot Breakdown of academic impact, for papers by Maximilian Merz
Rankless by CCL
2026